|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,946 GBX | +0.29% |
|
-1.07% | +3.26% |
| Apr. 17 | AstraZeneca: presents new data at ECCMID | CF |
| Apr. 17 | The market is pinning its hopes on earnings reports |  |
Jan 26 (Reuters) - The U.S. Food and Drug Administration said on Thursday that AstraZeneca's COVID-19 antibody cocktail Evusheld is not currently authorized for use in the United States until further notice by the agency. (Reporting by Bhanvi Satija in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.26% | 211B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B | |
| -3.20% | 113B |
ASTRAZENECA PLC 
